Pediatric wish list
Executive Summary
FDA is asking that Congress remove the requirement for FDA to maintain a list of drugs needing pediatric study in reauthorizing the pediatric study incentive, Murphy said. Written agreements between FDA and sponsors detailing expectations expressed in written requests should also be eliminated, she said